Bronchiectasis

New England Journal of Medicine

Volumn 346, Issue 18, 2002, Pages 1383-1393

  Barker, Alan F ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHIECTASIS; CILIARY DYSKINESIA; CYSTIC FIBROSIS; DIAGNOSTIC TEST; DISEASE EXACERBATION; ENTERITIS; HEMOPTYSIS; HUMAN; IMMUNE DEFICIENCY; INFECTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RHEUMATOID ARTHRITIS; SYMPTOMATOLOGY;

ADMINISTRATION, INHALATION; ANTI-BACTERIAL AGENTS; BRONCHIECTASIS; DIAGNOSIS, DIFFERENTIAL; HEMOPTYSIS; HUMANS; LUNG; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0037007684     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMra012519     Document Type: Review

References (100)

1. Reduction in bronchial subdivision in bronchiectasis
2. Bronchiectasis in Alaska Native children: Causes and clinical courses
3. Inflammation: A two-edged sword - The model of bronchiectasis
4. Increases in CD4+ T lymphocytes, macrophages, neutrophils and interleukin 8 positive cells in the airways of patients with bronchiectasis
5. Sputum elastase in steady-state bronchiectasis
6. Interleukin-8: An important chemoattractant in sputum of patients with chronic inflammatory airway diseases
7. Neutrophil-mediated degradation of lung proteoglycans: Stimulation by tumor necrosis factor-alpha in sputum of patients with bronchiectasis
8. Effect of indomethacin on bronchorrhea in patients with chronic bronchitis, diffuse panbronchiolitis, or bronchiectasis
9. Tracheobronchial foreign bodies in adults
10. Middle lobe syndrome: A clinicopathological study of 21 patients
11. Interventional pulmonology
12. Bronchiectasis in systemic diseases
13. Effect of pneumonia and whooping cough in childhood on adult lung function
14. An investigation into causative factors in patients with bronchiectasis
15. Determinants of chronic infection with Staphylococcus aureus in patients with bronchiectasis
16. Infection with Mycobacterium avium complex in patients without predisposing conditions
17. Mycobacterium avium-intracellulare pulmonary infection in HIV-negative patients without preexisting lung disease: Diagnostic and management limitations
18. A mutation in the interferon-γ-receptor gene and susceptibility to mycobacterial infection
19. Analyses of the NRAMP1 and IFN-gammaR1 genes in women with Mycobacterium avium-intracellulare pulmonary disease
20. Review of fungus-induced asthmatic reactions
21. T cell subsets, epitope mapping, and HLA-restriction in patients with allergic bronchopulmonary aspergillosis
22. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis
23. Bronchiectasis in HIV disease
24. Bronchiectasis in pediatric AIDS
25. AIDS associated bronchiectasis: CT features
26. Primary ciliary dyskinesia
27. Primary ciliary dyskinesia: Diagnosis and standards of care
28. Characterization of an axonemal dynein heavy chain expressed early in airway epithelial ciliogenesis
29. Loss-of-function mutations in a human gene related to Chlamydomonas reinhardtii dynein IC78 result in primary ciliary dyskinesia
30. Homozygosity mapping of a gene locus for primary ciliary dyskinesia on chromosome 5p and identification of the heavy dynein chain DNAH5 as a candidate gene
31. The primary immunodeficiencies
32. Clinical utility of highresolution pulmonary computed tomography in children with antibody deficiency disorders
33. Common variable immunodeficiency: Clinical and immunological features of 248 patients
34. IgG subclass deficiencies associated with bronchiectasis
35. IgG subclasses in the serum and sputum from patients with bronchiectasis
36. Recurrent sinopulmonary infection and impaired antibody response to bacterial capsular polysaccharide antigen in children with selective IgG-subclass deficiency
37. Characterization of specific immunoglobulin G (IgG) and its subclasses (IgG1 and IgG2) against the 23-valent pneumococcal vaccine in a healthy adult population: Proposal for response criteria
38. The use of intravenous immune globulin in immunodeficiency diseases
39. Cystic fibrosis
40. A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations
41. Bronchiectasis and rheumatoid arthritis: A clinical study
42. Bronchiectasis: A late feature of severe rheumatoid arthritis
43. Use of high resolution computed tomography of the lungs in patients with rheumatoid arthritis
44. High resolution computed tomography of the lung in lifelong non-smoking patients with rheumatoid arthritis
45. Decreased survival in patients with co-existent rheumatoid arthritis and bronchiectasis
46. The lung in inflammatory bowel disease
47. The lung in inflammatory bowel disease
48. Clinical and radiologic characteristics of lung disease in inflammatory bowel disease
49. The immunologic component of the cellular inflammatory infiltrate in bronchiectasis
50. Clinical, pathophysiologic, and microbiologic characterization of bronchiectasis in an aging cohort
51. Bronchiectasis
52. Comparison of thin section computed tomography with bronchography for identifying bronchiectatic segments in patients with chronic sputum production
53. Assessment of bronchiectasis: Comparison of HRCT and spiral volumetric CT
54. The reproducibiliry of bronchial circumference measurements using computed tomography
55. Bronchiectasis: Comparison of preoperative thin section CT and pathologic findings in resected specimens
56. Correlation of CT findings with clinical evaluations in 261 patients with symptomatic bronchiectasis
57. Reactive mediastinal lymphadenopathy in bronchiectasis assessed by CT
58. Thin-section CT detection of emphysema associated with bronchiectasis and correlation with pulmonary function tests
59. Bronchiectasis: Accuracy of high resolution CT in the differentiation of specific diseases
60. Uncomplicated asthma in adults: Comparison of CT appearance of the lungs in asthmatic and healthy subjects
61. Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care
62. Traction bronchiectasis in end-stage pulmonary fibrosis
63. Airways obstruction and bronchiectasis: Correlation with duration of symptoms and extent of bronchiectasis on computed tomography
64. Airflow obstruction in bronchiectasis: Correlation between computed tomography features and pulmonary function tests
65. Atopy, immunological changes, and respiratory function in bronchiectasis
66. Prevalence of asthma, atopy, and bronchial hyperreactivity in bronchiectasis: A controlled study
67. Pulmonary function tests and airway responsiveness to methacholine in chronic bronchiectasis of the adult
68. Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I
69. A comparative study on the efficacy of levofloxacin and ceftazidime in acute exacerbation of bronchiectasis
70. The bacteriology of bronchiectasis in Hong Kong investigated by protected catheter brush and bronchoalveolar lavage
71. Bacterial colonisation in patients with bronchiectasis: Microbiological pattern and risk factors
72. Dynamics of respiratory tract colonization by Branhamella catarrhalis in bronchiectasis
73. Influenza virus inhibits lysozyme secretion by sputum neutrophils in subjects with chronic bronchial sepsis
74. Bronchial inflammation and colonization in patients with clinically stable bronchiectasis
75. Effects of airway infection by Pseudomonas aeruginosa: A computed tomographic study
76. Validation of the St. George's Respiratory Questionnaire in bronchiectasis
77. The effect of Pseudomonas aeruginosa infection on clinical parameters in steady-state bronchiectasis
78. A pilot study of low-dose erythromycin in bronchiectasis
79. Efficacy and safety of long-term ciprofloxacin in the management of severe bronchiectasis
80. Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis
81. Inhaled gentamicin reduces airway neutrophil activity and mucus hypersecretion in bronchiectasis
82. Diagnosis and treatment of disease caused by nontuberculous mycobacteria
83. Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma: A preliminary report
84. Physiotherapy for airway clearance in adults
85. Long-term treatment of chronic bronchitis with positive expiratory pressure mask and chest physiotherapy
86. Bronchopulmonary hygiene physical therapy in bronchiectasis and chronic obstructive pulmonary disease: A systematic review
87. Inhaled steroids in patients with bronchiectasis
88. Inhaled fluticasone reduces sputum inflammatory indices in severe bronchiectasis
89. Pulmonary resection for multi-drug resistant tuberculosis
90. Resection of the right middle lobe and lingula for mycobacterial infection
91. Surgical management of bronchiectasis
92. Surgical treatment of bronchiectasis: 10 years' experience
93. Current surgical therapy for bronchiectasis
94. Current strategy for surgical management of bronchiectasis
95. Lung transplantation in cystic fibrosis: Consensus conference statement
96. Lung transplantation
97. Hemoptysis: Prospective high-resolution CT/bronchoscopic correlation
98. Immediate and long-term results of bronchial artery embolization for life-threatening hemoptysis
99. Bronchiectais: An orphan disease with a poorly-understood prognosis